Will apre stock go up?

Will apre stock go up?

Stock Price Forecast The 2 analysts offering 12-month price forecasts for Aprea Therapeutics Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +696.60% increase from the last price of 0.38.

Is apre a buy?

The consensus among 4 Wall Street analysts covering (NASDAQ: APRE) stock is to Buy APRE stock.

Why did Aprea Therapeutics stock drop?

Shares of clinical-stage biopharmaceutical company, Aprea Therapeutics, Inc APRE, plummeted 78% after it announced that the late-stage study evaluating the safety and efficacy of lead candidate, eprenetapopt, combined with azacitidine (AZA) versus AZA alone in TP53 mutant myelodysplastic syndromes (MDS) failed to meet …